These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 9689829

  • 1. IGF-1 and IGFBP-3 in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G, Rapa A, Boccardo G, Silvestro L, Chiorboli E.
    Panminerva Med; 1998 Jun; 40(2):103-6. PubMed ID: 9689829
    [Abstract] [Full Text] [Related]

  • 2. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G, Rapa A, Boccardo G, Silvestro L, Chiorboli E.
    Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423
    [Abstract] [Full Text] [Related]

  • 3. Effects of iodine deficiency on insulin-like growth factor-I, insulin-like growth factor-binding protein-3 levels and height attainment in malnourished children.
    Wan Nazaimoon WM, Osman A, Wu LL, Khalid BA.
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):79-83. PubMed ID: 8796142
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease.
    Wan Nazaimoon WM, Khalid BA.
    Horm Metab Res; 1998 Apr; 30(4):213-6. PubMed ID: 9623636
    [Abstract] [Full Text] [Related]

  • 5. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
    Schmid C, Zwimpfer C, Brändle M, Krayenbühl PA, Zapf J, Wiesli P.
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
    Akin F, Yaylali GF, Turgut S, Kaptanoglu B.
    Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
    [Abstract] [Full Text] [Related]

  • 7. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.
    Inukai T, Takanashi K, Takebayashi K, Fujiwara Y, Tayama K, Takemura Y.
    Horm Metab Res; 1999 Oct; 31(10):576-9. PubMed ID: 10596968
    [Abstract] [Full Text] [Related]

  • 8. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
    Li GM, Sun XJ, Shao P.
    Chin Med J (Engl); 2008 Oct 20; 121(20):2077-82. PubMed ID: 19080279
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun 20; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism?
    Giavoli C, Porretti S, Ferrante E, Cappiello V, Ronchi CL, Travaglini P, Epaminonda P, Arosio M, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2003 Dec 20; 59(6):806-10. PubMed ID: 14974926
    [Abstract] [Full Text] [Related]

  • 14. The endocrine consequences for very low birth weight premature infants.
    Cutfield WS, Regan FA, Jackson WE, Jefferies CA, Robinson EM, Harris M, Hofman PL.
    Growth Horm IGF Res; 2004 Jun 20; 14 Suppl A():S130-5. PubMed ID: 15135795
    [Abstract] [Full Text] [Related]

  • 15. [A study on the relationship between insulin-like growth factor, insulin-like growth factor-binding protein-3 and fetal growth retardation].
    Zhang P, Liu B, Li G, Wu L, Yu M, Ou Y, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb 20; 37(2):65-8. PubMed ID: 11953064
    [Abstract] [Full Text] [Related]

  • 16. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, Kirsch G, Sänger E, Engel G, Hamm AO, Nauck M, Meng W.
    Clin Endocrinol (Oxf); 2004 Jun 20; 60(6):750-7. PubMed ID: 15163340
    [Abstract] [Full Text] [Related]

  • 17. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR, de Faria ME, Osorio MG, Estefan V, Jorge AA, Arnhold IJ, Mendonca BB.
    Clin Endocrinol (Oxf); 2003 Dec 20; 59(6):788-92. PubMed ID: 14974923
    [Abstract] [Full Text] [Related]

  • 18. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB.
    Growth Horm IGF Res; 2008 Dec 20; 18(6):506-16. PubMed ID: 18550406
    [Abstract] [Full Text] [Related]

  • 19. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
    Yildiz B, Kural N, Colak O, Ak I, Akcar N.
    Clin Physiol Funct Imaging; 2008 Mar 20; 28(2):107-12. PubMed ID: 18093232
    [Abstract] [Full Text] [Related]

  • 20. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep 20; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.